Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.


Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
15 06 2021
Historique:
received: 03 12 2020
revised: 05 02 2021
accepted: 29 03 2021
pubmed: 3 4 2021
medline: 8 4 2022
entrez: 2 4 2021
Statut: ppublish

Résumé

To delineate recurrent oncogenic driver alterations and dysregulated pathways in esophageal adenocarcinoma and to assess their prognostic value. We analyzed a large cohort of patients with lower esophageal and junctional adenocarcinoma, prospectively sequenced by MSK-IMPACT with high-quality clinical annotation. Patients were subdivided according to treatment intent, curative versus palliative, which closely mirrored clinical staging. Genomic features, alterations, and pathways were examined for association with overall survival using Cox proportional hazard models, adjusted for relevant clinicopathologic factors knowable at the time of diagnosis. Analysis of 487 patients revealed 16 oncogenic driver alterations, mostly amplifications, present in ≥5% of patients. Patients in the palliative-intent cohort, compared with those in the curative-intent cohort, were more likely to have metastatic disease, Our study suggests that higher levels of genomic instability are associated with more advanced disease in esophageal adenocarcinoma. Furthermore,

Identifiants

pubmed: 33795256
pii: 1078-0432.CCR-20-4707
doi: 10.1158/1078-0432.CCR-20-4707
pmc: PMC8228505
mid: NIHMS1691679
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3491-3498

Subventions

Organisme : NCI NIH HHS
ID : K12 CA184746
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA217169
Pays : United States

Informations de copyright

©2021 American Association for Cancer Research.

Références

Oncotarget. 2016 Mar 1;7(9):10051-63
pubmed: 26840267
Arch Pathol Lab Med. 2016 Dec;140(12):1345-1363
pubmed: 27841667
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28890946
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
JCO Precis Oncol. 2017;2017:
pubmed: 30211344
J Natl Compr Canc Netw. 2019 Jul 1;17(7):855-883
pubmed: 31319389
Cancer Discov. 2018 Jan;8(1):49-58
pubmed: 29122777
J Clin Oncol. 2006 Sep 10;24(26):4347-55
pubmed: 16963732
Ann Cardiothorac Surg. 2017 Mar;6(2):119-130
pubmed: 28447000
Lancet. 2010 Aug 28;376(9742):687-97
pubmed: 20728210
Clin J Gastroenterol. 2020 Dec;13(6):1010-1021
pubmed: 32965635
Nucleic Acids Res. 2016 Sep 19;44(16):e131
pubmed: 27270079
Nat Genet. 2013 May;45(5):478-86
pubmed: 23525077
Dis Esophagus. 2016 Nov;29(8):897-905
pubmed: 27905172
Cancer Cell Int. 2019 Aug 22;19:216
pubmed: 31440117
Nature. 2017 Jan 12;541(7636):169-175
pubmed: 28052061
Nat Genet. 2018 Aug;50(8):1189-1195
pubmed: 30013179
Cancer Treat Rev. 2020 Jun;86:102024
pubmed: 32388292
Nat Genet. 2016 Oct;48(10):1131-41
pubmed: 27595477
Cancer. 2019 Jun 15;125(12):1990-2001
pubmed: 30973648
J Clin Oncol. 2013 Dec 10;31(35):4445-52
pubmed: 24127447
Gut. 2017 Mar;66(3):399-410
pubmed: 26733670
Nat Genet. 2020 Jan;52(1):74-83
pubmed: 31907488
J Thorac Cardiovasc Surg. 2018 Aug;156(2):847-856
pubmed: 30011772
Nat Rev Clin Oncol. 2018 Mar;15(3):139-150
pubmed: 29297505
Genome Res. 2012 Feb;22(2):398-406
pubmed: 21908773
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Cell. 2018 Apr 5;173(2):321-337.e10
pubmed: 29625050
Nat Genet. 2019 Mar;51(3):506-516
pubmed: 30718927
Nat Genet. 2019 Feb;51(2):202-206
pubmed: 30643254
Cancer Discov. 2018 Feb;8(2):174-183
pubmed: 29247016
J Mol Diagn. 2015 May;17(3):251-64
pubmed: 25801821
Nat Med. 2018 Jul;24(7):968-977
pubmed: 29808010
Am J Surg Pathol. 2015 Apr;39(4):487-95
pubmed: 25634752

Auteurs

Smita Sihag (S)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. sihags@mskcc.org.

Samuel C Nussenzweig (SC)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Henry S Walch (HS)

Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Meier Hsu (M)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Kay See Tan (KS)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Francisco Sanchez-Vega (F)

Colorectal Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Walid K Chatila (WK)

Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Sergio A De La Torre (SA)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Assem Patel (A)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Yelena Y Janjigian (YY)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Steven Maron (S)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Geoffrey Y Ku (GY)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Laura H Tang (LH)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.

Jaclyn Hechtman (J)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.

Pari M Shah (PM)

Department of Gastroenterology, Memorial Sloan Kettering Cancer Center, New York, New York.

Abraham J Wu (AJ)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

David R Jones (DR)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Daniela Molena (D)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

David B Solit (DB)

Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Nikolaus Schultz (N)

Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Michael F Berger (MF)

Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH